Molecular Imaging of Pulmonary Fibrosis

  • 0Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, Massachusetts.

Summary

This summary is machine-generated.

Molecular imaging offers a noninvasive way to track fibrotic lung disease progression. This review discusses novel imaging probes and challenges in developing them for better diagnosis and drug development.

Area Of Science

  • Pulmonary Medicine
  • Molecular Imaging
  • Biotechnology

Background

  • Fibrosing lung diseases impact over 160,000 people in the US, often with a poor prognosis.
  • Current antifibrotic therapies only slow disease progression, highlighting the need for improved treatments.
  • Molecular imaging allows in-vivo visualization of disease processes, offering a noninvasive approach to monitor fibrotic pathways.

Purpose Of The Study

  • To review molecular imaging probes currently under development for pulmonary fibrosis.
  • To discuss challenges in translating preclinical molecular imaging research into clinical applications.
  • To explore future directions for utilizing molecular imaging in drug development for fibrotic lung diseases.

Main Methods

  • Literature review of molecular imaging probes for pulmonary fibrosis.
  • Analysis of current challenges in clinical translation of imaging agents.
  • Discussion of future prospects for molecular imaging in pharmaceutical research.

Main Results

  • Several molecular imaging probes are in development for pulmonary fibrosis.
  • Significant hurdles exist in translating preclinical probes to clinical use.
  • Molecular imaging holds promise for improved diagnosis and monitoring of fibrotic lung diseases.

Conclusions

  • Molecular imaging is a promising tool for noninvasive monitoring and quantification of fibrotic lung disease.
  • Overcoming challenges in probe development and clinical translation is crucial for realizing its full potential.
  • Further research and development are needed to expand the clinical utility of molecular imaging in pulmonary fibrosis and drug discovery.